share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director DEPARLE NANCY ANN

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director DEPARLE NANCY ANN

西維斯健康 | 4:持股變動聲明-董事 DEPARLE NANCY ANN
美股SEC公告 ·  05/17 17:38
Moomoo AI 已提取核心訊息
Nancy Ann Deparle, reported a completed acquisition of CVS Health Corp (CVS) common stock on May 16, 2024. The transaction involved the purchase of 2,314 shares at a price of $57.52 per share. Following this transaction, Deparle directly holds a total of 31,838 shares in the company. The acquisition, characterized as a grant, award, or other acquisition, reflects a positive investment move in the company by the reporting person.
Nancy Ann Deparle, reported a completed acquisition of CVS Health Corp (CVS) common stock on May 16, 2024. The transaction involved the purchase of 2,314 shares at a price of $57.52 per share. Following this transaction, Deparle directly holds a total of 31,838 shares in the company. The acquisition, characterized as a grant, award, or other acquisition, reflects a positive investment move in the company by the reporting person.
南希·安·德帕勒報告說,已於2024年5月16日完成對CVS Health Corp(CVS)普通股的收購。該交易涉及以每股57.52美元的價格購買2314股股票。在這筆交易之後,Deparle直接持有該公司總共31,838股股份。此次收購以補助金、獎勵或其他收購爲特徵,反映了申報人對公司的積極投資舉措。
南希·安·德帕勒報告說,已於2024年5月16日完成對CVS Health Corp(CVS)普通股的收購。該交易涉及以每股57.52美元的價格購買2314股股票。在這筆交易之後,Deparle直接持有該公司總共31,838股股份。此次收購以補助金、獎勵或其他收購爲特徵,反映了申報人對公司的積極投資舉措。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息